# FDA Inspection 1323026 - Apex International Mfg., Inc - June 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/apex-international-mfg-inc/b0f06c32-0d4d-44d9-a1ac-e460cc329a05
Source feed: FDA_Inspections

> FDA Inspection 1323026 for Apex International Mfg., Inc on June 12, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1323026
- Company Name: Apex International Mfg., Inc
- Inspection Date: 2026-06-12
- Product Type: Human Drugs
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1036883 - 2017-10-31](https://www.keypedia.com/records/fda_inspections/apex-international-mfg-inc/4c078d00-eb1f-4ffb-8e00-185fd4d8afec)
- [FDA Inspection 911180 - 2015-01-27](https://www.keypedia.com/records/fda_inspections/apex-international-mfg-inc/ec77fc02-33f5-40f5-9a2a-b4dee6bd459a)

Company: https://www.keypedia.com/companies/apex-international-mfg-inc/7390b23d-581f-430f-b167-46089d661221

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d